This announcement is a separate document:
康方生物：自願公告 - 國家藥品監督管理局已受理依達方（依沃西，PD-1 /VEGF）單藥一線治療PD-L1表達陽性非小細胞肺癌的新適應症上市申請
AKESO: VOLUNTARY ANNOUNCEMENT - NMPA ACCEPTED THE SUPPLEMENTAL NEW DRUG APPLICATIONFOR IVONESCIMAB (PD-1/VEGF) MONOTHERAPY AS FIRST-LINETREATMENT FOR NSCLC WITH POSITIVE PD-L1 EXPRESSION
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated